Physician profile
Alison Garb
NPI 1467562140
$1,632.15
in general payments reported to CMS, 2019-2025
16 companies · $920 in 2025
The $920 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.30 · 2021: $109 · 2022: $70.41 · 2023: $344 · 2024: $173 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,436.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $851.36 | 2022-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $209.83 | 2023-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $135.59 | 2021-2025 | |
| Recordati_rare_diseases_inc. | $103.57 | 2025 | Isturisa |
| Pfizer INC. | $73.62 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $40.03 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.79 | 2025 | Trintellix |
| Lilly USA, LLC | $30.14 | 2025 | Zepbound, Mounjaro |
| Seqirus USA INC | $24.95 | 2025 | Fluad, Flucelvax |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.73 | 2024 | Xifaxan |
| Bausch Health US, LLC | $21.07 | 2022 | |
| Exact Sciences Corporation | $18.00 | 2025 | Cologuard Collection Kit |
| Acella Pharmaceuticals, LLC | $17.00 | 2025 | NP Thyroid 60 |
| Allergan, INC. | $16.30 | 2019 | |
| Esperion Therapeutics, INC. | $15.88 | 2025 | Nexletol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $14.29 | 2024 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Garb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.